T. Rowe Price U.S. Equity Research holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
T. Rowe Price U.S. Equity Research Fund PRCOX
- NAV / 1-Day Return 74.98 / −0.69 %
- Total Assets 18.8B
-
Adj. Expense Ratio
0.450%
- Expense Ratio 0.450%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.56%
- Turnover 47%
USD | NAV as of Jun 16, 2026 | 1-Day Return as of Jun 16, 2026, 10:13 PM GMT+0
Morningstar’s Analysis PRCOX
Will PRCOX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the PRCOX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of PRCOX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 8.00 | 1B | Technology |
Apple Inc | 6.67 | 1B | Technology |
Microsoft Corp | 4.93 | 872M | Technology |
Amazon.com Inc | 4.31 | 763M | Consumer Cyclical |
Alphabet Inc Class C | 3.82 | 675M | Communication Services |
Broadcom Inc | 3.44 | 609M | Technology |
Alphabet Inc Class A | 2.83 | 501M | Communication Services |
Meta Platforms Inc Class A | 2.31 | 408M | Communication Services |
Tesla Inc | 1.63 | 288M | Consumer Cyclical |
Eli Lilly and Co | 1.30 | 229M | Healthcare |
United States